ask="7.40"
ask_size="100"
average_daily_volume="35698"
bid="4.90"
bid_size="100"
book_value="1.99"
change="+0.07"
change_from_200_day_moving_average="-0.67"
change_from_50_day_moving_average="0.28"
change_from_52_week_high="-3.98"
change_From_52_week_low="0.93"
change_in_percent="+1.08%"
close="6.53"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.87"
ebitda="-10.01M"
eps_estimate_current_year="-0.62"
eps_estimate_next_quarter="-0.13"
eps_estimate_next_year="-1.01"
ex_dividend_date="N/A"
float_shares="8645000"
high="6.53"
high_52_weeks="10.51"
last_trade_date="1/5/2017"
last_trade_price="6.53"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.30"
low_52_weeks="5.60"
market_capitalization="86.61M"
moving_average_200_day="7.20"
moving_average_50_day="6.25"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.00"
open="6.51"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-9.35%"
percent_change_from_50_day_moving_average="+4.47%"
percent_change_from_52_week_high="-37.87%"
percent_change_from_52_week_low="+16.61%"
previous_close="6.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.25"
price_per_sales="133.67"
revenue="640999.00"
shares_outstanding="13264000"
short_ratio="6.22"
stock_exchange="NCM"
symbol="ORMP"
volume="16683"
weeks_range_52="5.60 - 10.51"
